September 07th, 2021
The Swiss Biotech Day is one of the leading biotechnology conferences in Europe coming back on stage on September 7, 2021 after the worldwide COVID-19 pandemic and will take place at Basel Congress Center.

Today, PROALT will present to investors and pharma companies the recent advances with the therapeutic monoclonal antibody PA-0661 developed for the treatment of metastatic colorectal cancer (mCRC) and other metastatic tumors like renal and melanoma, where cadherin targets play a critical role in metastasis formation and progression.